Hosted on MSN20d
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...
“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in face of Biosecure
At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...
Wall Street Journal20d
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million
The Chinese contract drugmaker will sell its vaccine factory in Dundalk, Ireland, to U.S.-based Merck for about $500 million, it said in an exchange filing late Monday. The facility, with a net ...
WuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade)
WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...
WuXi moves ahead with new $510M campus in Delaware despite sale of Navy Yard operations
A Chinese pharmaceutical company expects to hire up to 500 employees for the first phase of its new campus in northern ...
WuXi Biologics: Buy Rating Supported by Strong Performance, Strategic Growth, and Increased Target Price
CMB International Securities analyst Jill Wu has maintained their bullish stance on WXIBF stock, giving a Buy rating on January 13.Stay Ahead ...
Bloomberg L.P.21d
WuXi Bio to Sell Vaccine Facility to Merck for $500 Million
WuXi Biologics Cayman Inc. will sell a vaccine ... while continuing to navigate geopolitical tensions. The site at Dundalk, Ireland, which has been under construction since 2019, was designed ...